DOCSLIB.ORG

Printmgr File

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Printmgr File Page 1 of 1 <PAGE> ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------- FORM N-PX ----------------- ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-05577 ----------------- The Glenmede Fund, Inc. (Exact name of registrant as specified in charter) ----------------- c/o State Street Bank and Trust Company 100 Summer Street SUM0703 Boston, MA 02111 (Address of principal executive offices)(Zip Code) ----------------- Michael P. Malloy, Esq. Secretary Drinker Biddle & Reath LLP One Logan Square Suite 2000 Philadelphia, PA 19103-6996 (Name and address of agent for service) ----------------- Registrant’s telephone number, including area code: 1-800-442-8299 Date of fiscal year end: October 31 Date of reporting period: July 1, 2015 - June 30, 2016 ================================================================================ Page 1 of 1 <PAGE> Item 1. Proxy Voting Record. Page 1 of 342 <PAGE> ******************************* FORM N-Px REPORT ******************************* ICA File Number: 811-05777 Reporting Period: 07/01/2015 - 06/30/2016 The Glenmede Fund, Inc. ===================== Glenmede Core Fixed Income Portfolio ===================== The Core Fixed Income Portfolio, a series of the Registrant, did not hold any portfolio securities with respect to which the Portfolio was entitled to vote during the period from July 1, 2015 through June 30, 2016. ====================== Glenmede Government Cash Portfolio ====================== The Government Cash Portfolio, a series of the Registrant, did not hold any portfolio securities with respect to which the Portfolio was entitled to vote during the period period from July 1, 2015 through June 1, 2016 (termination of operations). ======================= Glenmede International Portfolio ======================= The proxy voting record of the International Portfolio, a series of the Registrant, during the period from July 1, 2015 through June 30, 2016 is filed herewith: ABB LTD. Ticker: ABBN Security ID: 000375204 Meeting Date: APR 21, 2016 Meeting Type: Annual Record Date: MAR 11, 2016 # Proposal Mgt Rec Vote Cast Sponsor 1 Accept Financial Statements and For For Management Statutory Reports 2 Approve Remuneration Report For For Management 3 Approve Discharge of Board and Senior For For Management Management 4 Approve Allocation of Income For For Management 5 Approve CHF 86 Million Reduction in For For Management Share Capital via Cancellation of Repurchased Shares 6 Approve CHF 1.6 Billion Reduction in For For Management Share Capital via Reduction of Nominal Value and Repayment of CHF 0.74 per Share 7 Amend Articles to Reflect Changes in For For Management Capital 8.1 Approve Remuneration of Directors in For For Management the Amount of CHF 4.7 Million 8.2 Approve Remuneration of Executive For For Management Committee in the Amount of CHF 50 Million 9.1 Reelect Matti Alahuhta as Director For For Management 9.2 Reelect David Constable as Director For For Management 9.3 Elect Frederico Fleury Curado as For Against Management Director 9.4 Elect Robyn Denholm as Director For For Management 9.5 Reelect Louis Hughes as Director For For Management 9.6 Elect David Meline as Director For For Management 9.7 Elect Satish Pai as Director For For Management 9.8 Reelect Michel de Rosen as Director For For Management 9.9 Reelect Jacob Wallenberg as Director For For Management 9.10 Reelect Ying Yeh as Director For For Management 9.11 Reelect Peter Voser as Director and For For Management Board Chairman 10.1 Appoint David Constable as Member of For For Management Page 2 of 342 the Compensation Committee 10.2 Appoint Frederico Fleury Curado as For Against Management Member of the Compensation Committee 10.3 Appoint Michel de Rosen as Member of For For Management the Compensation Committee 10.4 Appoint Ying Yeh as Member of the For For Management Compensation Committee 11 Designate Hans Zehnder as Independent For For Management Proxy 12 Ratify Ernst & Young as Auditors For For Management 13 Transact Other Business (Voting) For Against Management -------------------------------------------------------------------------------- ALLIANZ SE Ticker: ALV Security ID: 018805101 Meeting Date: MAY 04, 2016 Meeting Type: Annual Record Date: MAR 29, 2016 # Proposal Mgt Rec Vote Cast Sponsor 1 Receive Financial Statements and None None Management Statutory Reports for Fiscal 2015 (Non-Voting) 2 Approve Allocation of Income and For For Management Dividends of EUR 7.30 per Share 3 Approve Discharge of Management Board For For Management for Fiscal 2015 4 Approve Discharge of Supervisory Board For For Management for Fiscal 2015 5 Elect Friedrich Eichiner to the For For Management Supervisory Board A Counter Motion A Against Against Shareholder B Counter Motion B Against Against Shareholder C Counter Motion C Against Against Shareholder D Counter Motion D Against Against Shareholder E Counter Motion E Against Against Shareholder F Counter Motion F Against Against Shareholder G Counter Motion G Against Against Shareholder H Counter Motion H Against Against Shareholder -------------------------------------------------------------------------------- AMEC FOSTER WHEELER PLC Ticker: AMFW Security ID: 00167X205 Meeting Date: APR 27, 2016 Meeting Type: Annual Record Date: MAR 21, 2016 # Proposal Mgt Rec Vote Cast Sponsor 1 Accept Financial Statements and For For Management Statutory Reports 2 Approve Final Dividend For For Management 3 Approve Remuneration Report For For Management 4 Elect Roy Franklin as Director For For Management 5 Re-elect John Connolly as Director For For Management 6 Re-elect Ian McHoul as Director For For Management 7 Re-elect Linda Adamany as Director For For Management 8 Re-elect Neil Carson as Director For For Management 9 Re-elect Colin Day as Director For For Management 10 Re-elect Kent Masters as Director For For Management 11 Re-elect Stephanie Newby as Director For For Management 12 Reappoint Ernst & Young LLP as Auditors For For Management 13 Authorise Board to Fix Remuneration of For For Management Auditors 14 Authorise Issue of Equity with For For Management Pre-emptive Rights 15 Authorise Issue of Equity without For For Management Pre-emptive Rights 16 Authorise Market Purchase of Ordinary For For Management Shares 17 Authorise the Company to Call General For For Management Meeting with Two Weeks’ Notice -------------------------------------------------------------------------------- Page 3 of 342 AVIVA PLC Ticker: AV. Security ID: 05382A104 Meeting Date: MAY 04, 2016 Meeting Type: Annual Record Date: MAR 24, 2016 # Proposal Mgt Rec Vote Cast Sponsor 1 Accept Financial Statements and For For Management Statutory Reports 2 Approve Remuneration Report For For Management 3 Approve Final Dividend For For Management 4 Elect Claudia Arney as Director For For Management 5 Elect Andy Briggs as Director For For Management 6 Elect Belen Romana Garcia as Director For For Management 7 Elect Sir Malcolm Williamson as For For Management Director 8 Re-elect Glyn Barker as Director For For Management 9 Re-elect Patricia Cross as Director For For Management 10 Re-elect Michael Hawker as Director For For Management 11 Re-elect Michael Mire as Director For For Management 12 Re-elect Sir Adrian Montague as For For Management Director 13 Re-elect Bob Stein as Director For For Management 14 Re-elect Thomas Stoddard as Director For For Management 15 Re-elect Scott Wheway as Director For For Management 16 Re-elect Mark Wilson as Director For For Management 17 Reappoint PricewaterhouseCoopers LLP For For Management as Auditors 18 Authorise the Audit Committee to Fix For For Management Remuneration of Auditors 19 Authorise EU Political Donations and For For Management Expenditure 20 Authorise Issue of Equity with For For Management Pre-emptive Rights 21 Authorise Issue of Equity without For For Management Pre-emptive Rights 22 Authorise Market Purchase of Ordinary For For Management Shares 23 Authorise Market Purchase of For For Management Preference Shares 24 Authorise Market Purchase of For For Management Preference Shares 25 Authorise the Company to Call General For For Management Meeting with Two Weeks’ Notice 26 Authorise Issue of Equity in Relation For For Management to Any Issuance of SII Instruments 27 Authorise Issue of Equity without For For Management Pre-emptive Rights in Relation to Any Issuance of SII Instruments -------------------------------------------------------------------------------- AXA Ticker: CS Security ID: 054536107 Meeting Date: APR 27, 2016 Meeting Type: Annual/Special Record Date: MAR 18, 2016 # Proposal Mgt Rec Vote Cast Sponsor 1 Approve Financial Statements and For For Management Statutory Reports 2 Approve Consolidated Financial For For Management Statements and Statutory Reports 3 Approve Allocation of Income and For For Management Dividends of EUR 1.10 per Share 4 Advisory Vote on Compensation of Henri For For Management de Castries, Chairman and CEO 5 Advisory Vote on Compensation of Denis For For Management Duverne, Vice CEO 6 Approve Auditors’ Special Report on For For Management Related-Party Transactions 7 Reelect Stefan Lippe as Director For For Management 8 Reelect Francois Martineau as Director For For Management 9 Elect Irene Dorner as Director For For Management 10 Elect Angelien Kemna as Director For For Management 11 Reelect Doina Palici Chehab as For For Management Representative
Load more

Recommended publications
  • TARGET PORTFOLIO TRUST Form N-PX Filed 2017-08-30
    SECURITIES AND EXCHANGE COMMISSION FORM N-PX Annual report of proxy voting record of registered management investment companies filed on Form N-PX Filing Date: 2017-08-30 | Period of Report: 2017-06-30 SEC Accession No. 0000067590-17-000961 (HTML Version on secdatabase.com) FILER TARGET PORTFOLIO TRUST Mailing Address Business Address 655 BROAD STREET 655 BROAD STREET CIK:890339| IRS No.: 137000899 | State of Incorp.:DE | Fiscal Year End: 1031 17TH FLOOR 17TH FLOOR Type: N-PX | Act: 40 | File No.: 811-07064 | Film No.: 171060626 NEWARK NJ 07102 NEWARK NJ 07102 9738026469 Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document United States Securities and Exchange Commission Washington, DC 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number: 811-07064 The Target Portfolio Trust (Exact name of registrant as specified in charter) 655 Broad Street 17th Floor Newark, NJ 07102 (Address of principal executive offices) (Zip code) Jonathan D. Shain, Esquire 655 Broad Street 17th Floor Newark, NJ 07102 (Name and address of agent for service) Registrant’s telephone number, including area code: 973-802-6469 Date of fiscal year end: July 31 Date of reporting period: 7/1/2016 through 6/30/2017 Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Item 1. Proxy Voting Record. In determining votes against management, any ballot that management did not make a recommendation is considered to be "FOR" regardless of the vote cast.
    [Show full text]
  • NEUBERGER BERMAN ALTERNATIVE FUNDS Form N-PX
    SECURITIES AND EXCHANGE COMMISSION FORM N-PX Annual report of proxy voting record of registered management investment companies filed on Form N-PX Filing Date: 2017-08-24 | Period of Report: 2017-06-30 SEC Accession No. 0000898432-17-000842 (HTML Version on secdatabase.com) FILER NEUBERGER BERMAN ALTERNATIVE FUNDS Mailing Address Business Address 1290 AVENUE OF THE 1290 AVENUE OF THE CIK:1317474| IRS No.: 000000000 | State of Incorp.:DE | Fiscal Year End: 1031 AMERICAS AMERICAS Type: N-PX | Act: 40 | File No.: 811-21715 | Film No.: 171048680 NEW YORK NY 10104 NEW YORK NY 10104 (212) 476-8800 Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document As filed with the Securities and Exchange Commission on August 24, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-PX Annual Report of Proxy Voting Record of Registered Management Investment Company Investment Company Act file number: 811-21715 NEUBERGER BERMAN ALTERNATIVE FUNDS (Exact Name of the Registrant as Specified in Charter) c/o Neuberger Berman Investment Advisers LLC 1290 Avenue of the Americas New York, New York 10104-0002 (Address of Principal Executive Offices – Zip Code) Registrant's telephone number, including area code: (212) 476-8800 Robert Conti Chief Executive Officer and President Neuberger Berman Alternative Funds c/o Neuberger Berman Investment Advisers LLC 1290 Avenue of the Americas New York, New York 10104-0002 Arthur C. Delibert, Esq. K&L Gates LLP 1601 K Street, N.W.
    [Show full text]
  • Deka Vermögensmanagement Gmbh
    Abstimmungsergebnisse Deka Vermögensmanage- ment GmbH Zeitraum: 1. Januar 2020 – 31. Dezember 2020 Abstimmungsergebnisse Deka Vermögensmanagement GmbH ABB Ltd. Meeting Date: 26/03/2020 Country: Switzerland Meeting Type: Annual Ticker: ABBN Primary ISIN: CH0012221716 Primary SEDOL: 7108899 Proposal Vote Number Proposal Text Proponent Mgmt Rec Instruction 1 Accept Financial Statements and Statutory Mgmt For For Reports 2 Approve Remuneration Report (Non-Binding) Mgmt For For 3 Approve Discharge of Board and Senior Mgmt For For Management 4 Approve Allocation of Income and Dividends Mgmt For For of CHF 0.80 per Share 5 Amend Articles Re: Annual Report Mgmt For For 6.1 Approve Remuneration of Directors in the Mgmt For For Amount of CHF 4.7 Million 6.2 Approve Remuneration of Executive Mgmt For For Committee in the Amount of CHF 39.5 Million 7.1 Reelect Matti Alahuhta as Director Mgmt For For 7.2 Reelect Gunnar Brock as Director Mgmt For For 7.3 Reelect David Constable as Director Mgmt For For 7.4 Reelect Frederico Curado as Director Mgmt For Against 7.5 Reelect Lars Foerberg as Director Mgmt For For 7.6 Reelect Jennifer Xin-Zhe Li as Director Mgmt For For 7.7 Reelect Geraldine Matchett as Director Mgmt For For 7.8 Reelect David Meline as Director Mgmt For For 7.9 Reelect Satish Pai as Director Mgmt For For 7.10 Reelect Jacob Wallenberg as Director Mgmt For For 7.11 Reelect Peter Voser as Director and Board Mgmt For For Chairman 8.1 Appoint David Constable as Member of the Mgmt For For Compensation Committee 8.2 Appoint Frederico Curado as Member of the Mgmt For Against Compensation Committee 8.3 Appoint Jennifer Xin-Zhe Li as Member of the Mgmt For For Compensation Committee 9 Designate Hans Zehnder as Independent Mgmt For For Proxy 2 Abstimmungsergebnisse Deka Vermögensmanagement GmbH ABB Ltd.
    [Show full text]
  • News: Interview with Ornella Barra on Forbes Monaco
    THE NEXT BILLION DOLLAR SAFARI BUSINESS BILLION- A CASE FOR MONACO’S EU DEAL DOLLAR STARTUPS TRUMP UNCONSTRAINED THE $6 BILLION WEATHER WARS “I’ve always had an entrepreneurial mindset and curious att itude. This empowered me to envision pharmacy’s full potential.” SPECIAL ENTREPRENEURIAL WOMEN Over the Counter with Ornella Barra HOW THE COMMUNITY PHARMACIST TURNED M 31766 5 F : €9 RD DRUGSTORE MOGUL IS 00030 BREAKING THE GLASS 9.50 CEILING. 3 783176 609006 Benelux: AUGUST 2019 MONACO FEMALE ENTREPRENEURS THE PROFILE 42 43 RANKED LAST YEAR AS ONE OF THE MOST POWERFUL WOMEN IN BUSINESS OUTSIDE THE U.S., PHARMACIST ORNELLA BARRA FOUNDED A WHOLESALE BUSINESS IN 1984 THAT TWO YEARS LATER BECAME ITALY’S LEADING DRUG DISTRIBUTOR WHEN IT MERGED WITH ALLEANZA SALUTE ITALIA, HEADED BY STEFANO PESSINA. THE COUPLE’S GREAT CHEMISTRY HAS ENDURED OVER 35 YEARS AND BARRA IS NOW CO-COO OF THE WORLD’S LARGEST DRUGSTORE CHAIN, WALGREENS BOOTS ALLIANCE. OTHESE BOOTS ARE MADE FOR WALGREENS BY CELINA LAFUENTE DE LAVOTHA PHOTOTGRAPH BY THIERRY BEAUVILAIN OUVRARD AUGUST 2 019 FORBES MONACO ambitious drive, she knew her career options would be arra stepped into her co-COO role in today and we are right in the middle of this evolution. limited. She instead studied Pharmacy at the University of June 2016 and oversees Global Brands, The nature of medicines is changing, as we see with Genoa, then managed a local pharmacy before acquiring B Pharmaceutical Wholesale, the Retail the growing importance of pharmacogenetics [the one in her hometown in 1979. “I always wanted to build Pharmacy International businesses outside study of the role of the genome in drug response].” something important for myself and others.
    [Show full text]
  • Leading by Example Stefano Pessina Won the 2013 Clarity Search Retail Leader of the Year Award
    Sponsored by THE CLARITY SEARCH RETAIL LEADER OF THE YEAR Leading by example Stefano Pessina won the 2013 Clarity Search Retail Leader of the Year award. Tiffany Holland talks to the Alliance Boots executive chairman to find out why he’s ahead of the pack n first meeting, it’s easy Last year the self-made billionaire to guess that Stefano revealed that Alliance Boots would Pessina is an entrepre- be partnering with US drugstore Oneur. He wears the sort of chain Walgreens, which will even- sharp suits you’d expect of a billion- tually lead to a full merger. aire and his confident, composed It was one of the most remarkable air could calm any boardroom. business moves in years, as Alliance As the boss of Alliance Boots, Boots, which earned a trading profit one of the largest retailers in the UK of £1.2bn in the last financial year, and one of the biggest pharmaceuti- joined forces with Walgreens’ cal wholesalers in the world, he is empire of 8,000 stores. known for his serene demeanour – The US retailer generated an oper- something that was undoubtedly ating income of $3.5bn (£2.3bn) in useful last June when he brokered the same financial year. In June it the landmark retail deal of 2012. was revealed that Walgreens would But when Retail Week speaks to initially invest $6.7bn (£4.5bn) in him, the Italian businessman is in cash and stocks to acquire 45% high spirits, cracking jokes and equity in Alliance Boots, with a revelling in the recognition his view to merge within three years.
    [Show full text]
  • Give Me More! the New Marketing Mantra in Hair Care
    AN ISSUE OF WOMEN’S WEAR DAILY THE BUSINESS OF BEAUTY HOLLYWOOD’S RED CARPET WHIZ KIDS INFOMERCIAL-MANIA DOLLAR STORES CASH IN GIVE ME MORE! THE NEW MARKETING MANTRA IN HAIR CARE %%3*;&29(5DLQGG 30 $QQSPWFEXJUIXBSOJOHT WWD BEAUTY INC 3 FEATURES 26 Small Screen Dreams The infomercial channel is booming as established players look to solidify their CONTENTS position amidst an onslaught of new entrants. 30 Maximum Volume Hair-care marketers are aiming to transform the way women approach hair-care regimens—and pump up sales to boot. 36 Penny Press As one of the fastest-growing channels in retail, the value-oriented dollar stores are now also the most competitive. 40 Red Carpet Whiz Kids Hollywood’s hottest young hair stylists and makeup artists. DEPARTMENTS CORNER OFFICE 8 The Laugh Master Under Aurelian Lis, Benefit’s humorous ethos has flourished, but the brand’s explosive growth in North America is no joke. 10 Black Book: Brooke Wall The super-chic founder of The Wall Group shares her favorite L.A. haunts. 11 My First Job: Jerrod Blandino Getting creative at Chuck E. Cheese. BEAUTY BULLETIN 14 Pop Rocks Spring’s bright color palette. 16 Launch Window Key products hitting stores now. 18 Singular Sensations Inspired looks from the European runways. CONSUMER CHRONICLES 20 Tinseltown’s Newest Beauty Destination Testing the waters at Hollywood’s swanky new Walgreens. 24 Shopper Stalker Who’s buying what—and why– on Manhattan’s Upper West Side. MISC 6 Pete Unplugged Pete Born, WWD’s executive editor of beauty, surveys the global indie beauty scene.
    [Show full text]
  • Appendix II Selected Media Clips on Corruption and Anti-Competitive Allegations Against BAT (December 2015
    Appendix II Selected Media Clips on Corruption and Anti-Competitive Allegations against BAT (December 2015 - December 2016) ____________________________________________________ BBC November 30, 2015 The secret bribes of big tobacco paper trail Daily Mail November 30, 2015 BBC reports BAT tobacco giant paid bribes in east Africa Forbes December 1, 2015 An Exceptional Insight into Commercial Bribery Practices at British American Tobacco The Independent December 1, 2015 British American Tobacco accused of bribing senior politicians in order to sabotage anti-smoking laws The Independent December 18, 2015 British American Tobacco 'bribed' Kenyan politician Martha Karua to stop action against cigarette smuggling The Independent December 19, 2015 British American Tobacco paid union to disrupt production at one of its chief rivals, whistleblower claims The Telegraph February 25, 2016 BAT gives law firm 'open door' to probe corruption allegations The Independent February 27, 2016 British American Tobacco accused of corporate espionage in South Africa Spinwatch.org April 8, 2016 Revealed: BAT corruption scandal in Africa leads to London HQ Sunday Mail September 4, 2016 The man who blew the whistle on BAT The Lawyer December 8, 2016 BAT drops Linklaters from corruption probe in favour of Slaughter and May The secret bribes of big tobacco paper trail BBC November 30, 2015 http://www.bbc.co.uk/news/business-34944702 The BBC's Panorama programme has spent five months investigating bribery at British American Tobacco. BAT says it conducts its business with honesty, integrity and transparency, and has strict anti-bribery rules. But the BBC obtained hundreds of documents that reveal how BAT employees bribed politicians, public officials and even people working for a rival company in Africa.
    [Show full text]
  • Abstimmungsergebnisse Deka Investment Gmbh
    Abstimmungsergebnisse Deka Investment GmbH Zeitraum: 1. Januar 2018 – 31. Dezember 2018 Abstimmungsergebnisse Deka Investment GmbH 1&1 Drillisch AG Meeting Date: 17/05/2018 Country: Germany Meeting Type: Annual Ticker: DRI Primary ISIN: DE0005545503 Primary SEDOL: 5734672 Proposal Vote Number Proposal Text Proponent Mgmt Rec Instruction 1 Receive Financial Statements and Statutory Mgmt Reports for Fiscal 2017 (Non-Voting) 2 Approve Allocation of Income and Dividends Mgmt For For of EUR 1.60 per Share 3.1 Approve Discharge of Management Board Mgmt For For Member Vlasios Choulidis for Fiscal 2017 3.2 Approve Discharge of Management Board Mgmt For For Member Andre Driesen for Fiscal 2017 3.3 Approve Discharge of Management Board Mgmt For For Member Martin Witt for Fiscal 2017 4.1 Approve Discharge of Supervisory Board Mgmt For Against Member Michael Scheeren for Fiscal 2017 4.2 Approve Discharge of Supervisory Board Mgmt For For Member Kai-Uwe Ricke for Fiscal 2017 4.3 Approve Discharge of Supervisory Board Mgmt For For Member Kurt Dobitsch for Fiscal 2017 4.4 Approve Discharge of Supervisory Board Mgmt For For Member Norbert Lang for Fiscal 2017 4.5 Approve Discharge of Supervisory Board Mgmt For For Member Marc Brucherseifer for Fiscal 2017 4.6 Approve Discharge of Supervisory Board Mgmt For For Member Horst Lennertz for Fiscal 2017 4.7 Approve Discharge of Supervisory Board Mgmt For For Member Frank Rothauge for Fiscal 2017 4.8 Approve Discharge of Supervisory Board Mgmt For For Member Susanne Rueckert for Fiscal 2017 4.9 Approve Discharge
    [Show full text]
  • EPF Newsletter European Pharmacists Forum Newsletter – English Edition July 2019 Issue 55
    EPF Newsletter European Pharmacists Forum Newsletter – English edition July 2019 Issue 55 Twenty years of progress Ornella Barra, Co-Chief Operating Officer, Walgreens Boots Alliance, looks back at 20 years of progress for the European Pharmacists Forum sharing how it has evolved over the years to become a leading voice for independent pharmacy… The concept of EPF began when Alliance with the Boots Group and this brought Santé merged with Unichem in 1997 to EPF further opportunities to explore form Alliance Unichem, becoming one of expertise and best practice in healthcare the largest pan-European leaders across and beauty services, to complement the wholesale and retail. With such expertise existing independent pharmacy offer. and economies of scale, how could an independent pharmacist be able to My dear friend, Mike Smith, who is also capitalise on this and ensure they could the EPF’s inaugural President and current be part of the healthcare evolution? Who priority was primarily the dispensing of Chair of the EPF’s Stakeholder Group, would champion their voice? prescription medicines. However, with recently reflected on an early example increasing pressures on margins, many of how the EPF is at the forefront of For those who know me, pharmacy were asking how they could add value innovation in pharmacy. He shared with is in my DNA and I’m a passionate to their business. Through the EPF, we me, “In the late 90s, we held a Forum ambassador of pharmacy being at the were able to leverage the expertise of where there was a focussed discussion heart of healthcare.
    [Show full text]
  • HEALTH + Registered Offi Ce Helping People Look Alliance Boots Gmbh and Feel Their Best Baarerstrasse 94 CH-6300 Zug Switzerland
    Alliance Boots Boots Alliance Annual Report 2010/11 Annual For more information www.allianceboots.com HEALTH + Registered offi ce Helping people look Alliance Boots GmbH and feel their best Baarerstrasse 94 CH-6300 Zug Switzerland Contact [email protected] Alliance Boots Annual Report 2010/11 Overview Our performance in 2010/11 Glossary of key terms (for the year ended 31 March 2011) Constant currency Like for like revenue Trading profit Exchange rates applicable for the financial Like for like revenue on a constant currency basis Profit from operations before amortisation of information for the year ended 31 March 2010. compared to the comparable period in the customer relationships and brands, exceptional previous year. items and share of post tax earnings of EBITDA associates and joint ventures. Trading profit before underlying depreciation Net borrowings Revenue EBITDA Trading profit and amortisation. Cash and cash equivalents, restricted cash, Underlying depreciation and amortisation derivative financial instruments and borrowings Depreciation and amortisation adjusted to Exceptional items net of unamortised prepaid financing fees. exclude amortisation of customer relationships Items classified by Alliance Boots as exceptional and brands and depreciation and amortisation in nature. These are not regarded as forming Net finance costs within exceptional items. +15.1% +10 . 8 % +14 . 2 % part of the underlying trading activities of the Finance costs net of finance income. Group and so merit separate presentation to Underlying net finance costs allow stakeholders to understand the elements Restricted cash Net finance costs adjusted to exclude of financial performance and assess trends in Cash which is restricted for specific purposes exceptional items and timing differences within financial performance.
    [Show full text]
  • Carissimi Tutti
    Email di Annuncio – Eccezionalmente la SCUOLA approda al Forum Virtuale Women4Women - Mercoledì 12 maggio h.17:00 News del 6 Maggio 2021 Carissimi tutti, con una certa emozione e profondo senso di gratitudine voglio condividere con voi l’invito a partecipare al Forum Virtuale Women4Women - mercoledì 12 maggio h.17.00, augurandomi che siate in tanti ad aderirvi. Grazie al dott. Alfredo Ambrosetti ho avuto modo di conoscere la dott.ssa Ornella Barra, entrambi persone di grande umiltà, veri giganti al servizio della Nazione. La dott.ssa Ornella Barra, genovese di nascita, laurea in Farmacia, è oggi Chief Operating Officer, International di Walgreens Boots Alliance, a capo, col compagno di vita e di lavoro Stefano Pessina, di una realtà presente dal Nord al Sudamerica, dall’Europa alla Cina. Un gruppo che ha il suo quartier generale a Chicago, gli uffici a Londra; lo stile di Ornella è, comunque, rimasto, virtualmente, genovese. Una delle donne più influenti al mondo, come riviste di settore l'hanno definita, che ha mantenuto un’estrema riservatezza nei modi e nello stile di vita. Vale la pena citare le sue parole: «Sono cresciuta in una famiglia di imprenditori. Mio padre e mia madre hanno sempre avuto una dedizione molto forte per il lavoro e per la famiglia. Grazie al loro esempio, ho sempre saputo che nella vita bisogna impegnarsi e spesso anche sacrificarsi. Ma non è solo senso del dovere quello che mi è stato trasmesso. Certo, è un elemento importante per la formazione di un giovane, donna o uomo che sia… Ma quello che conta davvero, e che nella mia educazione ho avuto la fortuna di ricevere, è lo spirito di iniziativa.
    [Show full text]
  • US Approves OTC Differin in First Retinoid Drug Switch
    OTC22-07-2016p1_OTC15/11/2005 p1&24 19/07/2016 12:57 Page 1 22 July 2016 COMPANY NEWS 2 US approves OTC Differin Moberg buys three brands 2 from Prestige J&J takes 19.9% stake 3 in Japan’s Ci:z Holdings in first retinoiddrugswitch WBA to enter South Korea 4 with Emart cne sufferers in the US will soon be able Taisho takes DHG stake 5 Ato buyGalderma’sadapalene-based to aid its expansion plans Differin Gel 0.1% without aprescription, Alibaba grabs Chinese pharmacy chain 6 after the Food and Drug Administration Japan’s Suntorypicks up 7 (FDA)approvedthe product for OTC sale. GSK’s drinks in Nigeria Differin is the first retinoid-based product Alphrema purchase grows 8 to be made available OTCfor the treatment of Urgo’s presence in Italy acne in the US, with adapalene the first new Pharmacy2U agrees merger 8 ingredient for treating acne to be switched in the country since the 1980s. The product has Differin Gel 0.1% is the first retinoid-based product to GENERAL NEWS 9 been approvedfor the OTCtreatment of acne be available OTC in the US vulgaris in people aged 12 years or older. vations to enhance skin health,”hesaid. German experts against 9 Miles Harrison, president and general man- Commenting on the switch, LesleyFurlong, switching metronidazole ager of Galderma, claimed that the switch would deputy director of the FDA’sOffice of New PRACopens safetyreview 10 be a“game-changer for consumers and the acne Drugs IV,said that millions of consumers, of modified paracetamol category”, butdid not give alaunch date for from adolescents to adults, would nowhave BAH wants EMA to move to Bonn 10 the OTCproduct.
    [Show full text]